Name:NADK2 5' guide Sequence:/AltR1/rCrA rArGrC rGrArU rGrGrG rArCrC rUrUrA rCrArG rGrUrU rUrUrA… and 1 more item

The University of Virginia awarded a contract to Integrated DNA Technologies Inc. on August 19, 2026, with a cumulative value of $153.00. The contract was executed in Virginia and involves the procurement of specialized molecular biology reagents for research purposes. The primary contractor will deliver two distinct Alt-R Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 complementary RNA (crRNA) products, each containing 36 bases with standard desalting purification at a 2 nanomole concentration level.

The two line items comprise chemically synthesized guide RNA sequences designated as NADK2 5' and NADK2 3', each priced at $76.80 per unit with a quantity of one unit each. Both products are to be delivered to Xinhua Zhan at the University of Virginia. These CRISPR-Cas9 crRNA molecules are commonly utilized in genome editing applications within academic research environments. No specific period of performance or place of performance distinct from the contracting organization has been identified in the available contract documentation.